Confirmation of NP137 Potential to Overcome Resistance to Immune Checkpoint - Clinical Trial Design and Interim Results to be Presented at ASCO and ESMO 2025 LYON, FRANCE, April 25, 2025 /⁨EINPresswire.com⁩/ -- NETRIS Pharma, a clinical-stage private …